Revance Therapeutics Inc (RVNC)
3.07
-0.01
(-0.32%)
USD |
NASDAQ |
Dec 23, 16:00
3.07
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Cash from Investing (Quarterly): 23.29M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | -4.562M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Ligand Pharmaceuticals Inc | -46.51M |
| MEI Pharma Inc | 14.70M |
| Cellectar Biosciences Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.09M |
| Cash from Financing (Quarterly) | -6.087M |
| Free Cash Flow | -194.91M |
| Free Cash Flow Per Share (Quarterly) | -0.3949 |
| Free Cash Flow to Equity (Quarterly) | -41.76M |
| Free Cash Flow to Firm (Quarterly) | -36.88M |
| Free Cash Flow Yield | -65.63% |